Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hermal

Division of Almirall SA
www.hermal.de

Latest From Hermal

Flush with AZ cash, Almirall seeks dermatology assets

Almirall has fresh funds and wants to spend them on acquiring new dermatology assets, CEO Eduardo Sanchiz said following the surprise announcement that the Spanish firm is to sell its respiratory portfolio to AstraZeneca.

Respiratory Cardiovascular

Almirall buys derma firm Aqua for $305m+

Spanish pharma group Almirall has agreed to acquire Aqua Pharmaceuticals, a privately owned prescription dermatology company based in the US. It will pay $305m up front, and up to $75m in additional payments contingent on certain regulatory and commercial milestones being met during 2014 and 2015. It will also pay $22.6m up front related to amortization of certain long-term tax assets.

Gastrointestinal Dermatology

Almirall in transformation promises growth from Q4

Spain's top domestic pharma company Almirall saw sales shrink in the first quarter, but says that it will move into sustainable growth from the fourth quarter.

Gastrointestinal Dermatology

Almirall mulls German exit after Sativex price drop

Almirall may pull MS drug Sativex off the German market after tortuous price negotiations with the German Health Insurance Funds have resulted in the price being slashed by more than 60%. A senior Almirall manager said the new price "no longer covers the financing of the product". Leaving the product on the market at the lower price could have implications elsewhere through reference pricing.

Cancer Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Almirall SA
  • Senior Management
  • Klaus Treudler, Gen. Mgr.
    James Robson, Dir., Fin.
  • Contact Info
  • Hermal
    Phone: (49) 40 722 5021
    Scholtzstrasse 3A
    Kurt Hermann
    Reinbeck bei Hamburg, B-2057
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register